Community-acquired pneumonie (CAP) - Staphylococcus aureus (non-MRSA)
Advices
Priority | Medication | Remarks |
---|---|---|
Medication: flucloxacilline iv loading dose 1000mg, 6000mg continuous per 24 hours 7 to 14 days |
Remarks:
|
|
Medication: clindamycine po 600mg 3dd or
cotrimoxazol (trimethoprim + sulfamethoxazol) po 960mg 2dd or
doxycycline po loading dose 200mg, 100mg 1dd or
moxifloxacine po 400mg 1dd |
Remarks:
|
Priority | Medication | Remarks |
---|---|---|
Medication: cefazoline iv loading dose 2000mg, 6000mg continuous per 24 hours 7 to 14 days |
Remarks:
|
|
Remarks:
|
Sources
- Link naar UMCG: CAP protocol
- SWAB richtlijn CAP 2024
-
Pubmed.gov publication # 38801783
Anpalagan K, Dotel R, MacFadden DR, Smith S, Voss L, Petersiel N, Marks M, Marsh J, Mahar RK, McGlothlin A, Lee TC, Goodman A, Morpeth S, Davis JS, Tong SYC, Bowen AC; Adjunctive Clindamycin Domain-Specific Working Group for the Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group. Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial. Clin Infect Dis. 2024 Sep 26;79(3):626-634. doi: 10.1093/cid/ciae289. PMID: 38801783; PMCID: PMC11426255.
-
van Steen, W.J.; Fliss, M.A.; Metz, E.; Filoda, K.; van den Berg, C.H.S.B.; Sinha, B.; Bathoorn, E. Case Report: Fatal Necrotizing Pneumonia by Exfoliative Toxin etE2-Producing Staphylococcus aureus Belonging to MLST ST152 in The Netherlands. Microorganisms 2025, 13, 1618. https://doi.org/10.3390/microorganisms13071618
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-211726.8
Updated: 07/22/2025 - 17:09
Status: Published
General comments
Bij fulminante abcederende necrotiserende Staphylococcus aureus pneumonie: overleg met arts-microbioloog of internist-infectioloog over uitbreiden van de antibiotische therapie t.b.v. toxineremming (zie referenties).
Totale behandelduur 7-14 dagen, afhankelijk van klinische respons.